Literature DB >> 9884037

Histological integration of allogeneic cancellous bone tissue treated by supercritical CO2 implanted in sheep bones.

P Frayssinet1, N Rouquet, D Mathon, A Autefage, J Fages.   

Abstract

UNLABELLED: Different chemical or physical methods of bone processing have been developed to decrease the antigenicity of allogeneic bone which may delay or prevent graft integration. We have developed a method based on delipidation and deproteination of the bone with a supercritical fluid and hydrogen peroxide. Cylinders of cancellous allogeneic bone treated in this way were implanted for four weeks, four months or eight months in holes drilled in sheep condyles or tibial plateau. Histological sections were then processed and analysed qualitatively and quantitatively using an image analysis software coupled to a light microscope. Measurements were made of the trabecular bone surface (BS/TS), the relative osteoid surface (OS/BS), the active osteoid surface (OS/BS), active resorption surface (Oc.S/BS) and the relative surface of newly formed bone. After four weeks, the control cylinders (non-treated allogeneic bone) had been invaded by cellular tissue composed of lymphocytes and plasmocytes surrounding remnants of the donor bone marrow tissue. The processed cylinders showed osteoid apposition at the surface of their external trabeculae. The trabecular bone and osteoid surfaces were significantly higher in the processed bone sections than in the control bone sections. After four months, most of the control material had been osteolysed and replaced by connective tissue containing lymphocyte islets, while the processed materials showed a large amount of bone synthesized at the surface of implant trabeculae which appeared fragmented and disseminated within the newly formed bone. All the histomorphometric parameters measured were significantly different from those of the control. By eight months, most of the control material had been totally osteolysed with very little bone ingrown in the implantation site. Only one control implant had been integrated. The processed cylinders were difficult to discern from the bone in which they were implanted. The parameters measured on the processed cylinders were significantly higher than those measured on the control sections. IN
CONCLUSION: the treatment applied to the bone enhanced allogeneic bone integration and could provide a new kind of tissue treatment for bone banking.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884037     DOI: 10.1016/s0142-9612(98)00124-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Recommendations and considerations for the use of biologics in orthopedic surgery.

Authors:  Stefan Zwingenberger; Christophe Nich; Roberto D Valladares; Zhenyu Yao; Maik Stiehler; Stuart B Goodman
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

2.  Effect of gamma rays and accelerated electron beam on medullary lipids decomposition: influence of dose and irradiation temperature.

Authors:  Anna Jastrzebska; Ewelina Grazka; Joanna Marowska; Grzegorz Gut; Izabela Uhrynowska-Tyszkiewicz; Artur Kaminski
Journal:  Cell Tissue Bank       Date:  2022-03-10       Impact factor: 1.522

Review 3.  Allograft Bone as Antibiotic Carrier.

Authors:  Heinz Winkler; Peter Haiden
Journal:  J Bone Jt Infect       Date:  2017-01-01

4.  Assessment of the efficiency of different chemical treatments and ultrasonic cleaning for defatting of cancellous bone samples.

Authors:  Fangxing Wang; Florian Metzner; Georg Osterhoff; Stefan Schleifenbaum
Journal:  Cell Tissue Bank       Date:  2021-10-29       Impact factor: 1.752

5.  Integral fixation titanium/polyetheretherketone cages for cervical arthrodesis: Two-year clinical outcomes and fusion rates using β-tricalcium phosphate or supercritical carbon dioxide treated allograft.

Authors:  Ralph J Mobbs; Tajrian Amin; Daniel Ho; Aidan McEvoy; Vedran Lovric; William R Walsh
Journal:  J Craniovertebr Junction Spine       Date:  2021-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.